On heels of Amgen lawsuit, FTC broadens investigation of PBMs

On heels of Amgen lawsuit, FTC broadens investigation of PBMs

Source: 
BioPharma Dive
snippet: 

The Federal Trade Commission told two group purchasing organizations to supply information and records on their business practices as part of a larger probe of pharmacy benefit managers.

Zinc Health Services, founded in 2020, and Ascent Health Services, founded in 2019, will have 90 days to respond after receiving the orders, the FTC said Wednesday. Zinc negotiates rebates with drugmakers on behalf of CVS Caremark, while Ascent works with Express Scripts, Prime Therapeutics, Envolve Pharmacy Solutions and Humana Pharmacy Solutions, the FTC said.